News | Cardiac Imaging | November 30, 2020

AI-based Cardiac CT Image Three-dimensional Analysis Fully Automated Medical Device

AI Medic Inc. has obtained official product certification from the NIDS for its own medical video analysis software, AutoSEG

AI Medic Inc. has obtained official product certification from the NIDS for its own medical video analysis software, AutoSEG

November 30, 2020 — AI Medic Inc. announced that it has obtained official product certification from the NIDS (National Institute of Medical Device Safety Information) for its own medical video analysis software called "AutoSEG". "AutoSEG" is the only medical device in the world that automatically shapes a highly difficult coronary artery in three dimensions without expert intervention, assisting the diagnosis of diseases such as heart angina and myocardial infarction.

AutoSEG, which has been certified as a product by the NIDS, is a medical device that can automatically extract the coronary artery, aorta, ventricle and atrial components of the heart from CT images through the fusion of AI (Artificial Intelligence) techniques and numerical algorithms, and shape them in three dimensions and accurately measure value.

The heart is the only organ that continues to exercise during CT scans, and measurement is very difficult. Previously released commercial software takes about 4 to 8 hours, even if experts do it themselves, using semi-automation that allows users to extract areas by hand. On the other hand, AI Medic's AutoSEG allows three-dimensional segmentation of heart components from heart CT images within 10 minutes without the help of experts.

In addition, AI Medic is currently developing HeartMedi, which implements non-invasive CT-FFR technology that analyzes fractional flow reserve (FFR) by combining corresponding Auto Segmentation technology with hemodynamic technology. The medical device, which can determine whether a coronary artery is diseased through a hemodynamic simulation, is currently in the final stage of clinical trials in Korea. CT-FFR is an innovative technology that can predict FFR with CT images only, and HeartMedi is a medical imaging assist software that implements this technology. In the case of conventional invasive methods, not only did the patient suffer pain and danger, such as injecting guide wire, pressure sensor, and drugs into the blood vessels, but HeartMedi from AI Medic is receiving market attention as it can overcome all of these limitations. The success of these technologies is expected to drastically reduce unnecessary stent procedures, and also help the health insurance budget's worsening health care system.

Based on this product certification, AI Medic is focusing its efforts on marketing 'AutoSEG' while successfully carrying out clinical trials of HeartMedi, and aims to supply products for diagnosing heart diseases in the future starting from this year, starting with the supply of research version products mainly at major university hospitals.

Meanwhile, AI Medic is a company established in 2014 and is a startup that analyzes the physiological phenomenon of the human body through AI and computer simulation and develops a technology to diagnose patient-specific cardiovascular and cerebrovascular diseases based on CT-FFR, a core technology of cardiovascular digital healthcare, and medical imaging technology. It has completed investments of 3 billion won from Magna Investment in May 2018 and 7 billion won from Intervest in late March this year.

For more information: http://www.aimedic.kr/

Related Content

Brazilian researchers found that the higher the lung ultrasound score the greater the risk of ICU admission, intubation and death. Image courtesy of Julio Alencar

Brazilian researchers found that the higher the lung ultrasound score the greater the risk of ICU admission, intubation and death. Image courtesy of Julio Alencar

News | Coronavirus (COVID-19) | February 11, 2021
February 11, 2021 — ...
The research collaboration agreement covers a joint clinical retrospective study on liver fibrosis severity in Non-Alcoholic Steato-Hepatitis (NASH) patients
News | Artificial Intelligence | February 10, 2021
February 10, 2021 — Median Technologies announced the company has signed a research collaboration agreement with the
Unhealthy lifestyles, various diseases, stress, and aging can all contribute to an imbalance between the production of ROS and the body's ability to reduce and eliminate them. The resulting excessive levels of ROS cause "oxidative stress".

Unhealthy lifestyles, various diseases, stress, and aging can all contribute to an imbalance between the production of ROS and the body's ability to reduce and eliminate them. The resulting excessive levels of ROS cause "oxidative stress". Graphic courtesy of National Institutes for Quantum and Radiological Science and Technology

News | Magnetic Resonance Imaging (MRI) | February 10, 2021
February 10, 2021 — Oxygen is essential for human life, but within the body, certain biological environmental conditi
Comparison of breast cancer mortality rates (red squares) and distant-stage breast cancer incidence rates from SEER9 (blue dots) and SEER18 (green dots) per 100,000 for white women aged, A, 20–39, B, 40–69, and, C, 70–79 years (3,7,8).

Comparison of breast cancer mortality rates (red squares) and distant-stage breast cancer incidence rates from SEER9 (blue dots) and SEER18 (green dots) per 100,000 for white women aged, A, 20–39, B, 40–69, and, C, 70–79 years (3,7,8). Image courtesy of Radiology 

News | Breast Imaging | February 10, 2021
February 10, 2021 — Breast cancer death rates have stopped declining for women in the U.S.
 Nuance Communications, Inc. announced the acquisition of Saykara, Inc., a like-minded startup focused on developing a mobile AI assistant to automate clinical documentation for physicians. The acquisition underscores Nuance's ongoing expansion of market and technical leadership in conversational artificial intelligence (AI) and ambient clinical intelligence (ACI) solutions that reduce clinician burnout, enhance patient experiences, and improve overall health system financial integrity.
News | Artificial Intelligence | February 08, 2021
February 8, 2021 — ...

Images in 69-year-old man with biopsy-confirmed Gleason score 7 (3+4) prostate cancer. (a) Pretreatment axial T2-weighted fast spin-echo MRI scan (repetition time msec/echo time msec, 3820/97) shows tumor in midline anterior transition zone (arrow). (b) Intraoperative MRI scan shows contoured rectal wall (red line), prostate margin (blue outline), and region of interest (orange outline). Because the urethra was included in planned treatment volume, a suprapubic catheter was placed for continuous bladder drainage during treatment. (c) Intraoperative MRI scan shows focused ultrasound beam path (blue) overlaid on treatment plan. Rectangles illustrate each sonication spot. (d) Thermal map image obtained during treatment with heat deposition color coded in red overlaid on sonication spot. (e) Axial gadopentetate dimeglumine-enhanced MRI scan (230/2.97) obtained immediately after treatment shows devascularized ablated volume (arrows). (f) Corresponding T2-weighted fast spin-echo MRI scan (3820/97) at 5 months after ablation shows complete involution of transition zone. All seven cores from treatment area margins were negative for cancer at biopsy. Image courtesy of the Radiological Society of North America

News | Prostate Cancer | February 05, 2021
February 5, 2021 — A technique that delivers...
Materialise engineers coordinated the development of a surgical plan and created an on-screen 3D model based on CT-scans.

Materialise engineers coordinated the development of a surgical plan and created an on-screen 3D model based on CT-scans.

Feature | Medical 3-D Printing | February 03, 2021
Three-dimensional technologies, developed by Materialise